Rangesh Abinand's Form 4 filing
Tecogen Inc. (TGEN) · filed Jun 30, 2026
- Accession no.
- 0001537435-26-000047
- Filed
- Jun 30, 2026
- Trade date
- Jun 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001537435-26-000086 (Sep 8, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rangesh AbinandCIK 0001917503 | Director, Officer (Chief Executive Officer), Other: Chief Financial Officer |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | AGrant or awardAcquired | +174,081 | –F1 | – | 174,081 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | AGrant or awardAcquired | +26,041 | $5.17 | +$134,631.97 | 26,041 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted Stock Award pursuant to 2022 Stock Incentive Plan. Vests 25% per year.
Referenced by the price of 1 transaction in Table I.